<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2018-12-21</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000946486</issuerCik>
        <issuerName>WINDTREE THERAPEUTICS INC /DE/</issuerName>
        <issuerTradingSymbol>WINT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001730485</rptOwnerCik>
            <rptOwnerName>Panacea Venture Healthcare Fund I, L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O KPCB CHINA, UNIT 27 XIN KANG GARDEN</rptOwnerStreet1>
            <rptOwnerStreet2>1273 HUAI HAI ZHONG ROAD</rptOwnerStreet2>
            <rptOwnerCity>SHANGHAI</rptOwnerCity>
            <rptOwnerState>F4</rptOwnerState>
            <rptOwnerZipCode>200031</rptOwnerZipCode>
            <rptOwnerStateDescription>CHINA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isTenPercentOwner>1</isTenPercentOwner>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4527345</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series F Warrants</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.6800</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2018-12-21</value>
            </exerciseDate>
            <expirationDate>
                <value>2020-06-21</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>769649</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series G Warrants</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>4.0500</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2018-12-21</value>
            </exerciseDate>
            <expirationDate>
                <value>2023-12-21</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1494024</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series D Warrants</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>4.0000</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2019-01-02</value>
            </exerciseDate>
            <expirationDate>
                <value>2023-07-02</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>187500</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote (2)</value>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These securities of the Issuer are directly held by Panacea Venture Healthcare Fund I, L.P. Panacea Venture Healthcare Fund GP I, L.P. is the general partner of Panacea Venture Healthcare Fund I, L.P. Panacea Venture Healthcare Fund GP Company, Ltd. is the general partner of Panacea Venture Healthcare Fund GP I, L.P. Huang Zuie-Chin and Hai Mi are the directors of Panacea Venture Healthcare Fund GP Company, Ltd. By virtue of these relationships, Panacea Venture Healthcare Fund GP I, L.P., Panacea Venture Healthcare Fund GP Company, Ltd., Huang Zuie-Chin and Hai Mi each may be deemed to indirectly beneficially own the securities held by Panacea Venture Healthcare Fund I, L.P., however each disclaims beneficial ownership of such securities, except to the extent of its or his pecuniary interest therein.</footnote>
        <footnote id="F2">These securities of the Issuer are directly held by Panacea Venture Management Company Ltd. Huang Zuie-Chin and Hai Mi are the directors of Panacea Venture Healthcare Fund GP Company, Ltd. By virtue of these relationships, Huang Zuie-Chin and Hai Mi may be deemed to indirectly beneficially own the securities held by Panacea Venture Management Company Ltd., however each disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ James Huang as director</signatureName>
        <signatureDate>2018-12-31</signatureDate>
    </ownerSignature>
</ownershipDocument>
